Using a cohort of breast cancer patients for which we had obtained data on multiple cytokines, including CXCL8 as well as immune infiltration, we have first performed an extensive review of available CXCR2 Ab, as CXCR2 immunostaining remains controversial. Here, CXCR2 is linked to breast carcinoma.